Skip to content

Clinical trials

Insulinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulinoma Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20032
20044
20053
20062
20073
20081
20091
20103
20121
20132
20145
20151
20161
20172
20182
20194
20202
20211
20234
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Terminated9
Recruiting8
Unknown status8
Withdrawn5
Available2
Active, not recruiting2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Peking Union Medical College Hospital5
British Columbia Cancer Agency3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
ECOG-ACRIN Cancer Research Group2
Eastern Cooperative Oncology Group2
Memorial Sloan Kettering Cancer Center2
Rezolute2
Vanderbilt-Ingram Cancer Center2
Yale University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulinoma62
Glucagonoma33
Somatostatinoma31
Gastrinoma30
Carcinoma, Islet Cell26
Vipoma20
Adenoma, Islet Cell17
Neoplasms15
Carcinoma, Medullary10
Hypoglycemia9

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.